| Quarter (USD) | Dec 24 | Sep 24 | Jun 24 | Mar 24 | |
|---|---|---|---|---|---|
| Revenue | |||||
| Cost of revenue | |||||
| Operating income | |||||
| Operating margin | |||||
| Net income | |||||
| Net profit margin | |||||
| Cash on hand | |||||
| Change in cash | |||||
| Diluted EPS |
| Annual (USD) | Dec 24 | Dec 23 | Dec 22 | Dec 21 | |
|---|---|---|---|---|---|
| Revenue | |||||
| Cost of revenue | |||||
| Operating income | |||||
| Operating margin | |||||
| Net income | |||||
| Net profit margin | |||||
| Cash on hand | |||||
| Change in cash | |||||
| Diluted EPS |
| Cash burn rate (est.) | Burn method: Change in cash | Burn method: Operating income | Burn method: FCF (opex + capex) | Last Q | Avg 4Q | Last Q | Avg 4Q | Last Q | Avg 4Q |
|---|---|---|---|---|---|---|
| Cash on hand (at last report) | 43.48 mm | 43.48 mm | 43.48 mm | 43.48 mm | 43.48 mm | 43.48 mm |
| Cash burn (monthly) | (no burn) | (no burn) | 5.52 mm | 4.72 mm | 3.05 mm | 3.74 mm |
| Cash used (since last report) | n/a | n/a | 11.49 mm | 9.82 mm | 6.35 mm | 7.78 mm |
| Cash remaining | n/a | n/a | 31.99 mm | 33.67 mm | 37.13 mm | 35.71 mm |
| Runway (months of cash) | n/a | n/a | 5.8 | 7.1 | 12.2 | 9.6 |
| 13F holders | Current |
|---|---|
| Total holders | 82 |
| Opened positions | 13 |
| Closed positions | 15 |
| Increased positions | 28 |
| Reduced positions | 19 |
| 13F shares | Current |
|---|---|
| Total value | 168.92 bn |
| Total shares | 113.87 mm |
| Total puts | 0.00 |
| Total calls | 0.00 |
| Total put/call ratio | – |
| Largest owners | Shares | Value |
|---|---|---|
| Orbimed Advisors | 22.36 mm | $41.15 bn |
| Adage Capital Partners GP, L.L.C. | 11.13 mm | $20.48 bn |
| BX Blackstone | 10.03 mm | $18.45 bn |
| Blackstone Holdings II | 9.50 mm | $9.78 mm |
| Commander Aggregator | 7.79 mm | $31.15 mm |
| BlackRock | 6.82 mm | $12.55 bn |
| MPM Oncology Impact Management | 5.64 mm | $10.38 bn |
| Rock Springs Capital Management | 5.63 mm | $10.36 bn |
| Foresite Capital Fund V | 4.40 mm | $0.00 |
| Vanguard | 4.28 mm | $7.88 bn |
| Date | Owner | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
|---|---|---|---|---|---|---|---|---|---|---|
| 11 Feb 25 | James P Boylan | Stock Option Common Stock | Grant | Acquire A | No | No | 3.65 | 40,000 | 146.00 k | 40,000 |
| 11 Feb 25 | Jonathan Anderman | Stock Option Common Stock | Grant | Acquire A | No | No | 3.65 | 280,000 | 1.02 mm | 280,000 |
| 11 Feb 25 | Gordon Carl L | Stock Option Common Stock | Grant | Acquire A | No | No | 3.65 | 40,000 | 146.00 k | 40,000 |
| 11 Feb 25 | Philip Ferneau | Stock Option Common Stock | Grant | Acquire A | No | No | 3.65 | 40,000 | 146.00 k | 40,000 |
| 11 Feb 25 | Ellen Chiniara | Stock Option Common Stock | Grant | Acquire A | No | No | 3.65 | 40,000 | 146.00 k | 40,000 |
